To help you find the right patient assistance option for you, we've created the Patient Assistance Tool. Just enter some simple information to find out which service you're eligible for.
You Might Qualify for a Referral to the Genentech BioOncology Co-pay Card
Genentech BioOncology® Access Solutions can refer you to the Genentech BioOncology Co-pay Card. It can help you with the out-of-pocket costs of your Genentech medicine, if you’re eligible.*
*In order to be eligible for the Genentech BioOncology Co-pay Card, the patient must have commercial insurance, must not have Medicare, Medicaid or other government insurance, and must meet other eligibility criteria. They also must agree to the rules set forth in the terms and conditions for the program. Please visit CopayAssistanceNow.com for the full list of terms and conditions.
You Might Qualify for a Referral to an Independent Co-pay Assistance Foundation
If you need help with your co-pay for your Genentech medicine, we can refer you to an independent co-pay assistance foundation.*
*Independent co-pay assistance foundations have their own rules for eligibility. We cannot guarantee a foundation will help you. We only can refer you to a foundation that supports your disease state. We do not endorse or show financial preference for any particular foundation. The foundations we refer you to are not the only ones that might be able to help you.
You Might Qualify for a Referral to the Genentech® Access to Care Foundation, or GATCF
GATCF can help you receive your Genentech medicine free of charge, if you qualify.*
*If you have health insurance, you must have already tried other types of patient assistance to qualify for free Genentech medicine from GATCF. This includes the Genentech BioOncology Co-pay Card and support from independent co-pay assistance foundations. You must also meet financial criteria. If you do not have insurance, you must meet different financial criteria.
TECENTRIQ® Access Solutions
TECENTRIQ Access Solutions is a resource for people who take TECENTRIQ. We do all we can to connect you to the medicine you need.
Learn more at Genentech-Access.com/TECENTRIQ
Genentech® Access to Care Foundation (GATCF)
You may also be eligible for the Genentech® Access to Care Foundation (GATCF), which helps people who have health insurance and those who don’t. If you qualify for GATCF, you could receive TECENTRIQ free of charge.
Learn more about these resources here.
Genentech BioOncology™ Co-pay Card Program
Genentech offers the Genentech BioOncology Co-pay Card Program to help you with the out-of-pocket (OOP) costs of TECENTRIQ. The Co-pay card is not health insurance or a benefit plan.
The Co-pay card is available to you or your loved one if you are 18 years or older and covered by commercial (also known as private) insurance. You or your loved one must also live and receive treatment in the United States or Puerto Rico, be receiving TECENTRIQ for an FDA-approved indication, and not be receiving assistance through the Genentech® Access to Care Foundation or any other co-pay charitable organization.
Click here to learn more about the Genentech BioOncology Co-pay Card.
IMPORTANT SAFETY INFORMATION AND INDICATION
TECENTRIQ is a prescription medicine used to treat:
a type of bladder and urinary tract cancer called urothelial carcinoma.
- TECENTRIQ may be used when your bladder cancer:
- has spread or cannot be removed by surgery (advanced urothelial carcinoma), and
- you are not able to take chemotherapy that contains a medicine called cisplatin, or
- you have tried chemotherapy that contains platinum, and it did not work or is no longer working
It is not known if TECENTRIQ is safe and effective in children. The approval of TECENTRIQ in these patients is based on a study that measured response rate and duration of response. There is an ongoing study to confirm clinical benefit.
What is the most important information about TECENTRIQ?
TECENTRIQ can cause your immune system to attack normal organs and tissues in many areas of your body and can affect the way they work. These problems can sometimes become serious or life threatening and can lead to death.
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may delay or completely stop treatment with TECENTRIQ if you have severe side effects.
Call or see your healthcare provider right away if you get any symptoms of the following problems or these symptoms get worse.
TECENTRIQ can cause serious side effects, including:
- Lung problems (pneumonitis)–signs and symptoms may include new or worsening cough, shortness of breath, and chest pain
- Liver problems (hepatitis)–signs and symptoms of hepatitis may include yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), drowsiness, dark urine (tea colored), bleeding or bruising more easily than normal, and feeling less hungry than usual
- Intestinal problems (colitis)–signs and symptoms of colitis may include diarrhea (loose stools) or more bowel movements than usual, blood in your stools or dark, tarry, sticky stools, and severe stomach area (abdomen) pain or tenderness
- Hormone gland problems (especially the pituitary, thyroid, adrenal glands, and pancreas)–signs and symptoms that your hormone glands are not working properly may include headaches that will not go away or unusual headaches, extreme tiredness, weight gain or weight loss, dizziness or fainting, feeling more hungry or thirsty than usual, hair loss, changes in mood or behavior (such as decreased sex drive, irritability, or forgetfulness), feeling cold, constipation, your voice gets deeper, urinating more often than usual, nausea or vomiting, and stomach area (abdomen) pain
- Nervous system problems (neuropathy, meningitis, encephalitis)–signs and symptoms of nervous system problems may include severe muscle weakness, numbness or tingling in hands and feet, fever, confusion, changes in mood or behavior, extreme sensitivity to light, and neck stiffness
- Inflammation of the eyes–signs and symptoms may include blurry vision, double vision, or other vision problems, and eye pain or redness
- Severe infections–signs and symptoms of infection may include fever, cough, frequent urination, flu-like symptoms, and pain when urinating
- Severe infusion reactions–signs and symptoms of infusion reactions may include chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, fever, feeling like passing out, back or neck pain, and swelling of your face or lips
Before you receive TECENTRIQ, tell your healthcare provider about all your medical conditions, including if you:
- Have immune system problems (such as Crohn’s disease, ulcerative colitis, or lupus); have had an organ transplant; have lung or breathing problems; have liver problems; have a condition that affects your nervous system (such as myasthenia gravis or Guillain-Barré syndrome); or are being treated for an infection
- Are pregnant or plan to become pregnant
- TECENTRIQ can harm your unborn baby
- If you are able to become pregnant, you should use an effective method of birth control during your treatment and for at least 5 months after the last dose of TECENTRIQ
- Are breastfeeding or plan to breastfeed
- It is not known if TECENTRIQ passes into your breast milk
- Do not breastfeed during treatment and for at least 5 months after the last dose of TECENTRIQ
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of TECENTRIQ in people with urothelial carcinoma include:
- Feeling tired
- Decreased appetite
- Urinary tract infection
TECENTRIQ may cause fertility problems in females, which may affect the ability to have children. Talk to your healthcare provider if you have concerns about fertility.
These are not all the possible side effects of TECENTRIQ. Ask your healthcare provider or pharmacist for more information.